1. Salameh, WA, Mastrogiannis, DS. Maternal hyperlipidemia in pregnancy. Clin Obstet Gynecol. 1994; 37, 66–77.
2. Potter, JM, Nestel, PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979; 133, 165–170.
3. Woollett, LA. Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation. Am J Clin Nutr. 2005; 82, 1155–1161.
4. Napoli, C, D’Armiento, FP, Mancini, FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. J Clin Invest. 1997; 100, 2680–2690.
5. McConihay, JA, Horn, PS, Woollett, LA. Effect of maternal hypercholesterolemia on fetal sterol metabolism in the Golden Syrian hamster. J Lipid Res. 2001; 42, 1111–1119.
6. Liguori, A, D’Armiento, FP, Palagiano, A, et al. Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids. BJOG. 2007; 114, 1547–1556.
7. Leiva, A, de Medina, CD, Salsoso, R, et al. Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II. Arterioscler Thromb Vasc Biol. 2013; 33, 2444–2453.
8. Marseille-Tremblay, C, Ethier-Chiasson, M, Forest, JC, et al. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev. 2008; 75, 1054–1062.
9. Widschwendter, M, Schröcksnadel, H, Mörtl, MG. Pre-eclampsia: a disorder of placental mitochondria? Mol Med Today. 1998; 4, 286–291.
10. Bringhenti, I, Ornellas, F, Mandarim-de-Lacerda, CA, Aguila, MB. The insulin-signaling pathway of the pancreatic islet is impaired in adult mice offspring of mothers fed a high-fat diet. Nutrition. 2016; 32, 1138–1143.
11. Kim, J, Kwon, YH. Effects of disturbed liver growth and oxidative stress of high-fat diet-fed dams on cholesterol metabolism in offspring mice. Nutr Res Pract. 2016; 10, 386–392.
12. Knight-Lozano, CA, Young, CG, Burow, DL, et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation. 2002; 105, 849–854.
13. Gianotti, TF, Sookoian, S, Dieuzeide, G, et al. A decreased mitochondrial DNA content is related to insulin resistance in adolescents. Obesity. 2008; 16, 1591–1595.
14. Baardman, ME, Kerstjensfrederikse, WS, Berger, RM, et al. The role of maternal-fetal cholesterol transport in early fetal life: current insights. Biol Reprod. 2013; 88, 116–116.
15. Herrera, E, Ortega-Senovilla, H. Lipid metabolism during pregnancy and its implications for fetal growth. Curr Pharm Biotechnol. 2014; 15, 24–31.
16. Calabuig-Navarro, V, Haghiac, M, Minium, J, et al. Effect of maternal obesity on placental lipid metabolism. Endocrinology. 2017; 158, 2543.
17. Hastie, R, Lappas, M. The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity. Placenta. 2014; 35, 673–683.
18. Wallace, DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005; 39, 359–407.
19. Demir, D, Türkkahraman, D, Aktaş Samur, A, et al. Mitochondrial ATPase subunit 6 and cytochrome B gene variations in obese Turkish children. J Clin Res Pediatr Endocrinol. 2014; 6, 209–215.
20. Ling, C, Poulsen, P, Carlsson, E, et al. Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins. J Clin Invest. 2004; 114, 1518–1526.
21. Lin, J, Yang, R, Tarr, PT, et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell. 2005; 120, 261–273.
22. Johnson, WT, Anderson, CM. Cardiac cytochrome C oxidase activity and contents of subunits 1 and 4 are altered in offspring by low prenatal copper intake by rat dams. J Nutr. 2008; 138, 1269–1273.
23. Liu, J, Chen, D, Yao, Y, et al. Intrauterine growth retardation increases the susceptibility of pigs to high-fat diet-induced mitochondrial dysfunction in skeletal muscle. Plos One. 2012; 7, e34835.
24. Qiu, C, Sanchez, SE, Hevner, K, et al. Placental mitochondrial DNA content and placental abruption: a pilot study. BMC Res Notes. 2015; 8, 447.
25. Maloyan, A, Mele, J, Muralimanoharan, S, et al. Placental metabolic flexibility is affected by maternal obesity. Placenta. 2016; 45, 69–69.
26. Finck, BN, Kelly, DP. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest. 2006; 116, 615–622.
27. Knutti, D, Kralli, A. PGC-1, a versatile coactivator. Trends Endocrinol Metabol. 2001; 12, 360–365.
28. Puigserver, P, Spiegelman, BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine Rev. 2003; 24, 78–90.
29. Jornayvaz, FR, Shulman, GI. Regulation of mitochondrial biogenesis. Essays Biochem. 2010; 47, 69.
30. Johri, A, Chandra, A, Beal, MF. PGC-1α, mitochondrial dysfunction, and Huntington’s disease. Free Radic Biol Med. 2013; 62, 37–46.
31. Lin, J, Wu, PH, Tarr, PT, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α, null mice. Cell. 2004; 119, 121–135.
32. Scarpulla, RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. BBA Mol Cell Res. 2011; 1813, 1269–1278.
33. Lai, L, Leone, TC, Zechner, C, Schaeffer, PJ, et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 2008; 22, 1948–1961.
34. Meldrum, DR, Casper, RF, Diez-Juan, A, et al. Aging and the environment affect gamete and embryo potential: can we intervene? Fertil Steril. 2016; 105, 548–559.
35. Mandò, C, De, PC, Stampalija, T, et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metabol. 2014; 306, 404–413.